Lam Research Corporation $LRCX Stock Holdings Decreased by USS Investment Management Ltd

Key Points

• USS Investment Management Ltd reduced its holdings in Lam Research Corporation by 22.8%, selling 67,066 shares and bringing its total ownership to 226,636 shares valued at $16.47 million.
• Lam Research recently reported earnings of $1.33 per share for the quarter, exceeding analysts' estimates of $1.21, with revenue reaching $5.17 billion, up 33.6% year-over-year.
• The company announced a quarterly dividend increase from $0.23 to $0.26 per share, reflecting an annual yield of 1.0%, with the next payment scheduled for October 15th.

USS Investment Management Ltd trimmed its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 22.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 226,636 shares of the semiconductor company's stock after selling 67,066 shares during the quarter. USS Investment Management Ltd's holdings in Lam Research were worth $16,474,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the business. Meridian Wealth Management LLC grew its stake in Lam Research by 1.4% during the 1st quarter. Meridian Wealth Management LLC now owns 9,732 shares of the semiconductor company's stock worth $707,000 after buying an additional 130 shares during the last quarter. GW&K Investment Management LLC grew its stake in Lam Research by 10.1% during the 1st quarter. GW&K Investment Management LLC now owns 1,534 shares of the semiconductor company's stock worth $112,000 after buying an additional 141 shares during the last quarter. Dorsey & Whitney Trust CO LLC grew its position in shares of Lam Research by 1.2% during the first quarter. Dorsey & Whitney Trust CO LLC now owns 12,498 shares of the semiconductor company's stock worth $909,000 after acquiring an additional 146 shares during the last quarter. Citizens National Bank Trust Department grew its position in shares of Lam Research by 34.0% during the first quarter. Citizens National Bank Trust Department now owns 603 shares of the semiconductor company's stock worth $44,000 after acquiring an additional 153 shares during the last quarter. Finally, Progressive Investment Management Corp grew its position in shares of Lam Research by 0.4% during the first quarter. Progressive Investment Management Corp now owns 42,581 shares of the semiconductor company's stock worth $3,096,000 after acquiring an additional 156 shares during the last quarter. Institutional investors own 84.61% of the company's stock.

Analyst Ratings Changes

Several research analysts have commented on LRCX shares. Erste Group Bank started coverage on shares of Lam Research in a research report on Thursday, August 14th. They issued a "buy" rating for the company. KeyCorp increased their price objective on Lam Research from $105.00 to $115.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Needham & Company LLC increased their price objective on Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Morgan Stanley reissued an "underweight" rating and issued a $92.00 price target (down previously from $94.00) on shares of Lam Research in a research note on Tuesday, September 2nd. Finally, The Goldman Sachs Group assumed coverage on Lam Research in a research note on Thursday, July 10th. They issued a "buy" rating and a $115.00 price target for the company. Twenty equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Lam Research presently has an average rating of "Moderate Buy" and an average target price of $107.22.

Lam Research Trading Up 2.5%

Shares of LRCX stock opened at $102.95 on Friday. The stock has a 50-day simple moving average of $99.87 and a 200 day simple moving average of $85.82. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $108.02. The stock has a market capitalization of $130.30 billion, a P/E ratio of 24.75, a P/E/G ratio of 1.32 and a beta of 1.76. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. The firm had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm's revenue for the quarter was up 33.6% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, sell-side analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Wednesday, September 24th. This is a boost from Lam Research's previous quarterly dividend of $0.23. Lam Research's dividend payout ratio is 22.12%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.